Table 4.
Changes in vascular risk factor after follow-up period (6 months).
| After follow-up phytate diet (T2) | After follow-up non-phytate diet (T2) | ||||
|---|---|---|---|---|---|
| Median (Q1–Q3) | T1 vs T2 P value | Median (Q1–Q3) | T1 vs T2 P value | Intergroup P value | |
| Weight (kg) | 87 (80–95) | 0.369 | 87 (79–94) | 0.212 | 0.757 |
| BMI (kg/m2) | 36 (33–40) | 0.463 | 36 (33–39) | 0.225 | 0.844 |
| Waist (cm) | 109 (102–114) | 0.255 | 107 (102–115) | 0.653 | 0.465 |
| Hip (cm) | 110 (103–116) | 0.256 | 108 (103–117) | 0.644 | 0.274 |
| Waist/hip | 0.99 (0.96–1.02) | 0.064 | 0.99 (0.97–1.01) | 0.636 | 0.099 |
| Glucose (mg/dL) | 174 (135–211) | 0.823 | 166 (135–186) | 0.928 | 0.820 |
| Total cholesterol (mg/dL) | 171 (141–203) | 0.074 | 165 (140–191) | 0.707 | 0.475 |
| LDL cholesterol (mg/dL) | 100 (79–124) | 0.036 | 91 (70–115) | 0.278 | 0.189 |
| HDL cholesterol (mg/dL) | 38 (35–45) | 0.665 | 44 (38–49) | 0.239 | 0.621 |
| Triglycerides (mg/dL) | 136 (104–184) | 0.027 | 124 (100–171) | 0.127 | 0.033 |
| Insulin (µUI/mL) | 20 (12–46) | 0.357 | 20 (13–33) | 0.177 | 0.698 |
| Lipoprotein A (mg/dL) | 14.9 (3.9–64.0) | 0.071 | 12.5 (2.9–67.4) | 0.567 | 0.467 |
| hs-CRP (mg/dL) | 0.33 (0.19–0.57) | 0.537 | 0.42 (0.22–0.69) | 0.566 | 0.054 |
| Iron (µg/dL) | 79 (57–102) | 0.561 | 72.00 (61–88) | 0.967 | 0.976 |
| Ferritin (ng/mL) | 55 (20–102) | 0.405 | 32 (18–82) | 0.027 | 0.308 |
| Transferrin (mg/dL) | 268 (241–287) | 0.897 | 259 (249–276) | 0.139 | 0.337 |
| Transferrin saturation index (%) | 22 (17–27) | 0.381 | 20 (17–25) | 0.711 | 0.915 |
| Vitamin B12 (pg/mL) | 340 (269–470) | 0.694 | 366 (266–460) | 0.281 | 0.627 |
| Folate (ng/mL) | 6.7 (4.1–9.7) | 0.051 | 7.2 (6.2–8.4) | 0.344 | 0.041 |
| Leukocytes (×109/L) | 8.4 (6.6–9.8) | 0.144 | 8.1 (6.5–9.4) | 0.821 | 0.880 |
| Lymphocytes T1 (×109/L) | 2.6 (2.0–3.0) | 0.215 | 2.4 (1.8–3.2) | 0.530 | 0.655 |
| Lymphocytes (%) | 31 (28–39) | 0.284 | 32 (27–35) | 0.327 | 0.173 |
| Platelets (×106/L) | 259 (224–304) | 0.280 | 270 (242–308) | 0.095 | 0.457 |
| HOMA IR | 0.94 (0.50–1.70) | 0.153 | 0.65 (0.49–1.43) | 0.208 | 0.614 |
Un-adjusted within groups changes (after intervention, T1 vs. after follow-up period, T2) are given as median (interquartile range). Intra-groups analysis (T1 vs. T2) employed a paired-sample Wilcoxon signed-rank test or paired-samples t test to determine the significance of differences. Intergroup analysis (InsP6 diet vs. non-InsP6 diet) employed analysis of covariances and comparison between groups after adjusting for dietary intervention levels to determine the significance of differences.